Barclays 28th Annual Global Healthcare Conference March 11, 2026 12:00 PM EDTCompany ParticipantsRobin Cowie - CFO, Secretary ...

Assessing Bio-Rad Laboratories after recent performance Bio-Rad Laboratories (BIO) has attracted attention after a mixed stretch of returns, with the stock roughly flat over the past year but showing ...

Discover the leading players and innovations shaping the global biosensors market with the "Biosensors Companies Quadrant" report by 360 Quadrants. This comprehensive industry analysis evaluates over ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

Detailed price information for Agilent Technologies (A-N) from The Globe and Mail including charting and trades.

Biodesix expects to deliver $106 million to $112 million in annual revenue for 2026, representing 23% growth at the midpoint over 2025. The guidance includes consideration of recent weather events and ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the ...

ANN ARBOR, Mich., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today ...

Bio-Rad Laboratories, Inc. (NYSE:BIO) is one of the best debt-free mid-cap stocks to buy according to hedge funds. On February 12, Bio-Rad Laboratories, Inc. (NYSE:BIO) delivered solid fourth-quarter ...

Bio-Rad reported fourth-quarter revenue growth of 1.7% at constant currency and non-GAAP operating profit margin of 12%, or 180 basis points worse than last year's fourth quarter. The midpoints of ...